(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Amgen (NASDAQ:AMGN) and AstraZeneca (NASDAQ:AZN) announced Friday that their FDA-approved asthma therapy Tezspire reached ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.

Availability NasalFresh MD is now available for purchase at CVS stores nationwide and online at CVS.com and Nasalfreshmd.com.

I recently took a generic 12-hour, maximum-strength nasal decongestant to manage typical sinus pressure and congestion.

After that, three large, carefully designed studies were conducted—two by Merck for the treatment of seasonal allergies and ...

Treatment for nasal polyps often involves managing the underlying conditions contributing ... In some cases, surgery may be ...

The Food and Drug Administration proposed that oral phenylephrine be removed from store shelves saying that the treatment ...